Therapeutic Endometrial Biopsy
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Infertility
- Sponsor
- University of Aarhus
- Enrollment
- 300
- Locations
- 3
- Primary Endpoint
- Rate of clinical pregnancy
- Last Updated
- 8 years ago
Overview
Brief Summary
The aim of this study is to evaluate the potential benefits in implantation, clinical pregnancy and live birth rates by an endometrial biopsy prior to an IVF/ICSI treatment. Including a follow up on possible pregnancy complications and data on children at birth.
Further it is planned to aspirate secretions from the uterus and take blood samples during the treatment, which presumably can provide information about the mechanisms underlying the possible effect of the treatment.
Detailed Description
Randomized controlled prospective clinical study.
Investigators
Eligibility Criteria
Inclusion Criteria
- •One or more previous failed implantation despite transfer of good quality embryons/blastocyst in a fresh IVF/ICSI treatment
- •Planned Antagonist treatment
- •Planned Standardized hormone treatment
- •FSH: 2-12 IU/L
- •Age: 18-40 years
- •BMI: 18-32
- •Regular menstrual cycles
- •Written consent
Exclusion Criteria
- •Patients in need for a interpreter
- •Suspected intrauterine abnormalities ( fibromes, polyps, adenomyosis, sactosalpinges)
- •Planned use og Assisted hatching or use of specialized media
- •Previous inclusion in the study
Outcomes
Primary Outcomes
Rate of clinical pregnancy
Time Frame: Individual outcome will be evaluated within 8 weekes after embryo transfer. Overall outcome will be evaluated after 3 years.
Secondary Outcomes
- Rate of biochemical pregnancy(Individual outcome will be evaluated within 8 weeks after embryo transfer. Overall outcome will be evaluated after 3 years.)
- Rate of implantation(Individual outcome will be evaluated within 8 weekes after embryo transfer. Overall outcome will be evaluated after 3 years.)
- Rate of live birth(Individual outcome will be evaluated within 9 months after embryo transfer. Overall outcome will be evaluated after 3 years.)